Making Safety a Priority
Date: March 8, 2010
Providing a secure supply chain is one of the most important ways FFF Enterprises, Inc. distinguishes itself from other biopharmaceutical suppliers.
Drug counterfeiting is not a crime that is frequently in the news, but with the recent proliferation of fake flu shots flooding the Internet, that may be changing. One Temecula-based company has made fighting the war on prescription drug counterfeiting part of its mission. FFF Enterprises, Inc. is continually finding new ways to secure the biopharmaceutical supply chain and streamline delivery models for the critical-care products and vaccines it manages.
Biopharmaceutical suppliers often find themselves vulnerable to gray market criminals. Some statistics suggest that worldwide counterfeit pharmaceutical sales are increasing at about 13 percent annually - nearly twice the pace of legitimate pharmaceuticals. For many in the general public, concerns are minimal, based on the assumption that tampered drugs are found only through online sources. Sadly, it’s not just online customers who need to worry. Tainted drugs are landing at an alarming rate on local pharmacy shelves across the country, where they eventually make their way into the medicine cabinets of an unsuspecting public.
An industry leader, FFF Enterprises, Inc. has developed a number of innovative technologies that have helped transform distribution protocols among biopharmaceutical suppliers. The company’s first-of-its-kind Verified Electronic Pedigree™ (VEP) system electronically displays the chain of custody for every product it ships, and its LotTrack™ service tracks products by lot number and provides recall notification to those affected. Another example of FFF’s quality commitment is epitomized by its specialty pharmacy subsidiary, NuFACTOR, which was established to provide IVIG, coagulation factors and vaccines directly to patients. Other innovative programs include MyFluVaccine and VaxAmerica, which have provided revolutionary approaches to vaccination, streamlining access and administration to preventive vaccines for healthcare providers and patients.
“We are creating a standard for safety and excellence that we hope will continue to have a positive influence on the industry as a whole,” states Patrick M. Schmidt, chief executive officer, FFF Enterprises, Inc. “Our customers recognize the value of channel integrity to their patients and their bottom lines.”
Recognized as the most trusted distributor of biopharmaceuticals, plasma products and vaccines in the nation, FFF serves more than 80 percent of U.S. hospitals and supplies the nation’s leading non-acute care group purchasing organizations. With its emphasis on patient safety, FFF has incorporated from the bottom up what the pharmaceutical industry struggles to enact from the top down: a secure supply chain.